Abstract
Purpose.
To test the effectiveness and cost-effectiveness of a multilevel intervention for population-level African American (AA) severe maternal morbidity and mortality.
Background.
Severe maternal morbidity and mortality in the U.S. disproportionately affect AA women. Inequities occur at many levels, including community, provider, and health system levels.
Design.
Intervendtion.
Throughout the two intervention counties, we will expand access to enhanced prenatal care services using telehealth and flexible scheduling (community level), provide actionable maternal health-focused anti-racism training (provider level), and implement equity-focused community care maternal safety bundles (health system level).
Partnership.
Interventions were developed/co-developed by intervention county partners, including AA women, enhanced prenatal care staff, and health providers. For equity, 46% of project direct cost dollars go to our partners. Most study investigators are female (75%) and/or AA (38%). Partners are overwhelmingly AA women.
Sample, measures, analyses.
We use a quasi-experimental difference-in-differences with propensity scores approach to compare pre (2016–2019) to post (2022–2025) changes in outcomes for Medicaid-insured women in intervention counties to similar women in the other Michigan, USA, counties. The sample includes all Medicaid-insured deliveries in Michigan during these years (n~540,000), with women observed during pregnancy, at birth, and up to 1 year postpartum. Measures are taken from a linked dataset that includes Medicaid claims and vital records.
Conclusion.
This study is among the first to examine effects of any multilevel intervention on AA severe maternal morbidity and mortality. It features a rigorous quasi-experimental design, multilevel multi-partner county-wide interventions developed by community partners, and assessment of intervention effects using population-level data.
Keywords: maternal mortality, maternal health, maternal health services, African American, health disparity, healthcare disparities
1. Introduction
The U.S. maternal mortality rate is the highest among high-income countries.1,2 Pregnancy-related mortality rates doubled between 1987–2016 in the U.S., while declining in other high-income countries.1,2 Around 60% of the deaths are preventable.3 Of all deaths, approximately 1/3 occur during pregnancy, 1/3 at delivery or the week after, and 1/3 up to 1 year postpartum.2
Severe maternal morbidity (SMM; “unexpected outcomes of labor and delivery that result in significant short- or long-term consequences to a woman’s health”4) affects another 60,000 US women every year.5 The most common SMM include procedures in which women receive blood transfusions around delivery, hysterectomy, and ventilation/tracheostomy.2 These life-threatening complications affect mothers, families, and communities, and cost billions of dollars per year.6
SMM and maternal mortality disproportionately affect African American (AA) women. AA women are three to four times more likely to die of pregnancy related complications and have twice the SMM rate compared to non-Hispanic white (NHW) women.7,8 Inequities affecting SMM occur at multiple levels10 (e.g., community, health system, and provider/practice levels), yet very few studies examine multilevel interventions for SMM and maternal mortality disparities. The U.S. National Institutes of Health has called for additional research on multilevel interventions to reduce SMM and maternal mortality disparities.9
This protocol paper describes a study testing effectiveness and cost-effectiveness of a multilevel intervention (i.e., intervening at the community level, provider/practice level, and health system level) to reduce AA SMM and maternal mortality in two Michigan, U.S. counties. The Maternal Health Multilevel Intervention for Racial Equity (Maternal Health MIRACLE) Project uses a quasi-experimental difference-in-differences (DiD) with propensity scores approach to compare pre (2016–2019) to post (2022–2025) changes in outcomes among Medicaid-insured women in the two intervention counties with similar women in other Michigan counties. The study sample will include all Medicaid-insured deliveries in Michigan from 2016–2019 and 2022–2025 (~540,000 births, including ~162,000 births to AA women). Specific aims are to:
- Assess the effectiveness of the multilevel intervention on:
- AA SMM and a composite of SMM and pregnancy-related mortality (overall & relative to NHW women)
- AA non-severe maternal morbidity (overall & relative to NHW women)
Test improved service utilization and non-severe maternal morbidity (overall & relative to NHW women) as mechanisms (i.e., mediators) of the intervention’s effect on SMM
Evaluate the cost-effectiveness of the intervention
This study is among the first to examine effects of any multilevel intervention on AA SMM and mortality, and is the first to test this specific multilevel intervention. Novel aspects of the study include its rigorous quasi-experimental design, use of interventions at each level that were developed or co-developed by community partners in experimental counties, assessment of intervention effects using population-level data, and use of a unique statewide database system to assess study outcomes.
2. Method
2.1. Non-randomized pragmatic trial.
A non-randomized pragmatic trial design was chosen because randomizing individuals within counties to receive or not receive services associated with state or federally funded programs (such as an enhanced prenatal and postnatal care telehealth option) is not allowed by federal rules. Furthermore, individual-level randomization does not make sense for county-level interventions. County-level randomization is not possible because our intervention counties developed the interventions and thus would have to be in the intervention condition. The use of DiD with period-specific propensity score kernel weighting allows for effectiveness analyses using a non-randomized design, relying on observed individual and neighborhood characteristics to minimize bias.
2.2. Conceptual model and pilot work.
Disparities in maternal outcomes persist after controlling for patient characteristics (e.g., preconception health, health behaviors) and health care system factors (e.g., site and quality of care), suggesting that additional factors may be contributing to the high prevalence of maternal morbidity.9 The goal of our multilevel intervention is to help perinatal health systems engage and serve AA women more effectively to reduce disparities. The conceptual model framing our intervention merges the multiple levels where inequities occur highlighted by Howell10 and the right to health framework used by Black Mamas Matter Alliance11,12 (Figure 1). As described by Howell,10 inequities occur at multiple levels.
Figure 1. Conceptual model merging Howell multilevel inequities10 and the Right to Health Framework11,12.
For explanation of abbreviations, see Table 1.
2.2.1. Community level.
AA women disproportionately face community and neighborhood barriers to care.10,13–15 Working multiple jobs, limited access to quality childcare, unsafe neighborhoods, and transportation barriers can make it difficult to visit an office or accept home visiting services such as enhanced prenatal and postnatal care (EPC). EPC programs (such as Healthy Start and Michigan’s Maternal Infant Health Program) improve maternal care16 and reduce adverse birth outcomes, especially for AA women.17–21 However, up to two-thirds of eligible women nationally do not participate in EPC programs.22,23 In our pilot work before the COVID-19 pandemic, half of 50 interviewed women who declined these services said they would reconsider if they were offered via telehealth and with more flexible scheduling, including evenings and weekends. By offering EPC services via telehealth at flexible hours to those who decline traditional in-home services, we anticipate restructuring these services in a way that better fits the lived realities of many AA women. The goal is to modify community-based services to better accommodate the logistical challenges that women in low-income communities face.
2.2.2. Provider/practice level.
Clinicians’ explicit and implicit racial beliefs and attitudes are linked to quality of care,24,25 suggesting that racial bias in the health care system contributes to disparities in maternal morbidity and mortality.9 When AA women experience racial discrimination and inadequate care, especially during vulnerable moments in their health,26,27 this leads to adverse outcomes, mistrust of providers, and decreases likelihood of engaging health services in the future.28,29 We will focus on changing provider and health system biases and corresponding structures/practices using an actionable, maternal health focused anti-racism training. This training was developed and tested by AA women in Genesee County and found to be feasible, acceptable, and to result in improvements in provider knowledge, understanding of the effects of racism on maternal health, and familiarity with structural challenges AA women face and specific actions they can take to improve AA maternal health.14,30,31
2.2.3. Health system level.
Overall improvements in quality of obstetric care do not necessarily translate to reductions in racial disparities in maternal outcomes.9,32 Therefore, it is important for maternal care quality improvement interventions to target racial disparities.9 The National Healthy Start Association, with support from the U.S. Health Resources and Services Administration, has launched the Alliance for Innovation on Maternal health Community Care Initiative (AIM-CCI) to develop and implement equity-focused maternal safety bundles for community-based organizations and outpatient clinical settings.33 Our health system-level intervention will implement these equity-focused maternal care quality improvement bundles in intervention counties.
2.2.4. Proposed mechanisms.
We propose that (a) improved service utilization, and (b) reduced non-severe maternal morbidity will serve as mechanisms of the effect of the intervention on AA SMM. We use y/n enrollment in EPC, more (prenatal and postnatal) outpatient visits, and fewer (prenatal and postnatal) emergency department (ED) visits as positive service utilization indicators (Figure 1). NSMM will be defined as the sum of WHO-delineated NSMM diagnoses and procedures (details in Section 2.10.3). Number of NSMM will be tested as a mediator of the effects of study interventions on SMM because reducing NSMM (e.g., pre-eclampsia) reduces risk of SMM (e.g., eclampsia).
2.3. Equity and community engagement.
This project engages three kinds of partners. AA women from the target counties developed, implemented, honed, tested, and will lead the provider/practice level actionable antiracism intervention.14,30,34–37 EPC staff and leaders co-developed and will lead the community-level telehealth intervention. They are one of six national pilot sites for the AIM-CCI community care maternal safety bundles (our system-level intervention). Providers/health systems have provided input and/or feedback on interventions at all three levels. Representatives from all of these communities are valued members of the study team.
We have attended to study equity and representation. In this project, 46% of the direct cost dollars go to our partners. 75% of the study investigators are women; 38% of study investigators are AA. Partners are overwhelmingly AA and female.
2.4. Comparison condition: usual care.
Pregnant AA women in comparison counties (all Michigan counties except the two intervention counties) will receive whatever EPC services (i.e., the Maternal Infant Health Program and/or Healthy Start) they naturalistically choose to receive.
2.4.1. Maternal Infant Health Program (MIHP) as usual.
All pregnant women in Michigan who are Medicaid insured are eligible for MIHP. MIHP is an EPC program that offers at least monthly home visiting and care coordination to enhance medical care during pregnancy and up to 12 months post birth. MIHP offers care coordination by nurses and social workers, risk assessment, individual care plans, interventions matched to risk factors, and referrals (e.g. to address depression, domestic violence, health behaviors, basic needs, contraception). Before the COVID-19 pandemic, women were primarily served in their homes, with telehealth being the only option early in the pandemic. In-home visits are, again, becoming the norm. MIHP improves maternal and infant care,16 reduces risk of adverse birth outcomes,17 and reduces infant mortality.38 However, statewide, less than one third of women who are eligible enroll in MIHP.39
2.4.2. Healthy Start as usual.
Healthy Start is a federally funded program for women of color. It offers more intensive EPC services delivered by race/ethnicity concordant community health workers, whoare expected to have face-to-face contact every other week in women’s homes. Community health workers offer peer support; resilience and problem solving; risk assessment; facilitating provider-client communication; collaborative care; system navigation, including transition from prenatal care to postnatal primary care; and supportive referrals.27 Healthy Start is effective in reducing adverse birth outcomes. 1018,19 Healthy Start is offered in six of Michigan’s highest risk communities for AA infant mortality, including the two intervention and four of the comparison communities.
2.5. Intervention.
In addition to traditional EPC services, the following county-wide manualized intervention components will be offered in both intervention counties (see Table 2). The three intervention levels operate independently of each other.
Table 2.
Study interventions and assessments (whole table is new)
County-wide intervention component and years offered | Offered in control counties? | Offered in intervention counties? | Intervention fidelity assessment data collected by the project team (frequency) | Outcome assessment data from state records (frequency) |
---|---|---|---|---|
EPC (MIHP and Healthy Start) services as usual (all years) | Yes | Yes | NA | All linked Medicaid claims and vital records data from the entire state of Michigan for pre (2016–2019) and intervention (2022–2025) years |
Community level: EPC services also available via telehealth and outside business hours for women who decline EPC services as usual (2022–2025) | No | Yes | • Number of AA and non-AA women who declined traditional EPC services, who agreed to telehealth services, and who were served (monthly) | |
Provider/practice level: Maternal health focused actionable anti-racism for health-related providers and staff (2022 – 2025) | No | Yes | • Number trained (each training) • Provider pre, post, and 1 month follow-up surveys (each training) • Penetration (# trained/# eligible providers in county; end of study) |
|
Health system level: Implementation of AIM-CCI’s equity focused community care maternal safety bundles (2022 – 2025) | No | Yes | • Case notes documenting implementation activities (continuous) • Survey of knowledge and use of AIM-CCI bundle topics for the year (i.e., reach and adoption; annual) |
2.5.1. Community level (improving accessibility).
We will make EPC services (i.e., MIHP and Healthy Start) available via telehealth with flexible hours to women who are eligible for Healthy Start (primarily women of color) but who decline traditional MIHP or Healthy Start services. We do not anticipate that this intervention will change the dose or activities of EPC services, but rather that it will allow women to engage in EPC services who would otherwise decline. “Telehealth” EPC will include telehealth initially but could include face-to-face contact if desired by the participant. The goal is to have inclusive options to address patient preferences. We met with EPC providers to adapt core program components to telehealth delivery (e.g., mailing plans of care, demonstrating breastfeeding during video visits).
2.5.2. Provider/practice level (improving acceptability).
Our goal is to provide actionable maternal health-focused anti-racism training to anyone in intervention counties interacting with AA perinatal women related to their health, including health system administrators, physicians, residents, midwives, nurses, front desk staff, schedulers, public health officers, EPC staff, doulas, WIC staff, and lactation consultants (n~480).
The daylong actionable maternal health focused anti-racism training, occurring in groups of 10–20 every 6 weeks, will be led by the AA community partners who previously developed and led this training.14,31 Training includes a virtual tour of local neighborhoods to illustrate structural assets and challenges. Training will use actionable anti-racism and windshield tour manuals,14,31 which include discussion, reflection, and experiential activities covering: (1) health disparities and social determinants of health through an AA historical/cultural lens; (2) African and AA history that created current neighborhood and social structures; (3) historical, cultural, and structural impacts of racism and implications for maternal health and maternal mortality; (4) structural challenges and assets in high AA neighborhoods in each county and how they affect health; (5) how participating providers’ health and public health practices can better “meet women where they’re at,” and be respectful, flexible, and more responsive to their needs; (7) how to engage perinatal AA women as partners in improving health systems that serve them; and (8) setting actionable goals for their settings. Modules help participants brainstorm ways to tailor their practices to be more responsive to perinatal AA women.
2.5.3. Health system level (improving quality).
Kent County is one of six communities nationally (and the only one in Michigan) piloting AIM-CCI’s equity focused community care maternal safety bundles as they are developed by the national AIM-CCI group each year. Community care is defined as care provided by outpatient, EPC, community-based organizations, and linkages between hospital care and these settings. As part of AIM-CCI, Kent County planned to implement 2 bundles per year for 4 years (8 total) within outpatient clinical settings and community-based organizations. As part of this project, Genesee County will implement the bundles in partnership with Kent. Examples of planned bundles include “transition from maternity care to well-woman care,” “comorbidities,” and “maternal mental health.” The first bundle to be implemented was called “postpartum care basics for maternal safety.” It consisted of county-wide efforts to: (1) create pathways for systematic referral of all Medicaid-eligible pregnant women to EPC services; and (2) use the Center for Disease Control and Prevention’s (CDC’s) HEAR HER program,76 which identifies NSMM and SMM warning signs and appropriate responses for providers, patients, staff, and family members.
The charge from the national AIM-CCI initiative to the pilot sites is to “implement” the bundles. Our study team will partner with the county implementation teams to bring implementation science expertise to the process. We will manualize and systematize local implementation approaches, using Replicating Effective Programs40 to guide implementation activities and the RE-AIM framework41 to guide implementation assessment. We will also document implementation processes (see next section).
2.6. Intervention fidelity assessment.
At the community (telehealth option/flexible hours) level, we will ask our intervention county EPC (i.e., MIHP/Healthy Start) partners to report the following to us monthly: number of AA and non-AA women who declined traditional EPC services, who agreed to telehealth services, and who were served with these services.
At the provider/practice (actionable racism training) level, we will track: the number of health care providers participating in the trainings, penetration of these activities (number of providers trained divided by number eligible in each county),41 and electronic pre, post, and 1 month assessments of provider knowledge (e.g., of AA history, how race and racism can affect health) and expected/actual actions (e.g., I have changed something about my practice to reduce AA SMM and maternal mortality).14,30,31,42
At the system (AIM community care maternal safety bundle implementation) level, we will document implementation activities undertaken in both intervention counties using a structured implementation case note.43–47 Notes will document the actors, recipients, purpose, encounter length, a checklist of implementation strategies used (from Powell et al., 2015),48 a checklist of discussion topics, and free response sections. We will conduct annual county-wide electronic surveys asking about recipients’ knowledge and use of the AIM-CCI bundle topics for that year (i.e., bundle reach41) and actions taken to address each bundle guideline (i.e., bundle adoption41).
2.7. Study sample.
The study sample (n~540,000) will consist of all Medicaid insured deliveries in Michigan in 2016–2019 (pre-intervention cohorts) and 2022–2025 (post-intervention cohorts; 2020–2021 are transition years excluded from analyses). Medicaid covers 43% of all and 66% of AA births in the U.S.,49,50 disproportionately women who experience SMM or maternal mortality.51–53 Maternal race will be assessed based on birth records. County of residence at delivery (in data routinely collected by the state of Michigan; details below) will be used to assign women to intervention (i.e., Genesee and Kent counties) and comparison (i.e., all other Michigan) counties. Intervention counties and the rationale for choosing them are described in Table 3.
Table 3.
Description of Intervention Counties*
Genesee County | Kent County | Michigan | |
---|---|---|---|
Population | 406k | 657k | 9,987k |
Births per year (all) | 4.5k | 8.6k | 110k |
% Medicaid (all) | 56% | 31% | 42% |
Births to AA women | 1.4k | 1.3k | 22k |
% Medicaid (AA) | 83% | 61% | 66% |
Main metro area | Flint | Grand Rapids | -- |
% AA in metro | 55% | 20% | 14% |
Poverty in metro | 40% | 21% | 14% |
We chose Genesee and Kent counties as intervention counties because: (1) all levels of the multilevel intervention were developed in these counties; (2) both have Healthy Start; (3) both counties have high maternal morbidity and infant mortality;75 and (4) the counties represent different areas of Michigan (i.e., Eastern vs. Western Michigan).
2.8. Sample size and power.
The sample will include over 60,000 Medicaid insured deliveries in the intervention counties and close to 480,000 in the comparison counties over the 8 pre- and post-intervention birth cohorts. Approximately 30% of the deliveries will be AA women and 60% NHW. The SMM prevalence (main outcome) among Medicaid-insured deliveries in 2010 was 166/10,000;7 we assumed conservatively that it remained constant. We assumed for power calculations that the AA-NHW SMM prevalence ratio is 2 to 1. This study is powered to detect DiD intervention effects on reducing SMM among deliveries to AA women as small as relative risk of 0.84 with 80% power and 0.05 statistical significance assuming an intra-cluster correlation coefficient of 0.2. Because maternal mortality, even at a state level, is rare, our secondary outcome of maternal mortality will be accounted for as a composite of (SMM + maternal mortality; 1 if either, 0 otherwise).54,55 The available sample will allow us to detect smaller effects in disparities and in secondary outcomes, which include binary and non-binary assessments.
2.9. Data sources.
We will rely on the Michigan Department of Health and Human Services (MDHHS) Health Services Data Warehouse. Linked sources of data, all routinely collected or publicly available (e.g. census tract data), include: (1) complete Medicaid pregnancy and postpartum (12 months after birth) medical claims, including International Classification of Diseases (ICD-10) diagnostics and procedures; (2) monthly Medicaid enrollment during pregnancy and postpartum; (3) birth records, including data on pre-pregnancy and pregnancy risk factors (e.g. chronic disease, prior preterm); (4) maternal death records; (5) additional program data, including income level and participation in other programs (e.g. cash assistance); and (6) census tract data.
2.10. Assessments.
2.10.1. Covariates for propensity score estimation
will include age, education, married(y/n), father identified, alcohol use, tobacco use, prior preterm birth, a previous birth within 18 months of conception, and WIC participation, all from birth records via the MDHHS Health Services Data Warehouse. Medicaid eligibility and claims will be used to create an indicator for having Medicaid coverage three months prior to pregnancy. Census variables at the block group and census tract level will be used to adjust for poverty and household characteristics (e.g. % families in poverty, % families that are AA, Childhood Opportunity Index56, Area Deprivation Index57,58). An indicator will identify women living in counties where Healthy Start is offered.
2.10.2. Primary outcomes.
We will assess severe maternal morbidity (SMM, as defined by the American College of Obstetricians and Gynecologists and the CDC)4 using CDC’s list of 21 SMM indicators based on ICD-10 diagnosis and procedure codes.59 The binary overall SMM indicator will be coded 1 if any SMM is identified in antepartum, intrapartum, or 12 months postpartum Medicaid claims and 0 otherwise. Maternal death will be defined using the standard CDC definition of death from a pregnancy-related cause within one year of delivery or termination of pregnancy,2 a binary indicator defined as 1 if maternal death is identified on a death record linked to the pregnancy or delivery, and 0 otherwise. AA-NHW disparities will be defined as the percent difference between AA and NHW outcomes.
2.10.3. Secondary outcomes.
Measurement of “non-severe” maternal morbidity (NSMM), is taken from the WHO’s Maternal Morbidity Working Group.60–63 Most NSMM are measurable using ICD-10 diagnostic and procedure codes62,64 To capture multimorbidity in our sample, the overall NSMM indicator will be the sum of WHO-delineated NSMM diagnoses and procedures62,64 identified in a woman’s Medicaid claims during pregnancy and up to 1 year postpartum. We will also assess the following WHO-defined subcategories: (1) number of direct NSMM diagnoses and procedures (e.g., delivery complications, hypertensive disorders of pregnancy, obstetric hemorrhage, pregnancy-related infections);62 (2) number of indirect NSMM diagnoses and procedures (e.g. endocrine, nutritional, and metabolic diseases; mental disorders); and (3) number co-incidental NSMM (e.g. partner violence, sexual assault) diagnoses and procedures.62
2.10.4. Proposed mechanisms.
Service utilization will be operationalized using three separate indicators drawn from Medicaid claims and EPC program data, adjusted for number of months of Medicaid coverage: (1) EPC participation (MIHP and/or Healthy Start) defined as a binary indicator;16 (2) number of outpatient pregnancy and postpartum visits (higher is better); and (3) number of ED visits (lower is better). NSMM will be operationalized as the sum of all NSMM conditions, as described above.
2.10.5. Cost-effectiveness measures.
Our grant accounting will capture the costs of providing the multilevel intervention. The primary outcome used for cost-effectiveness analyses will be SMM. Prevented SMM will be monetized using Medicaid claims data by calculating the difference between Medicaid delivery expenditures between women with SMM and without SMM using our own claims data and prior estimates.6 Secondary cost-effectiveness measures will be maternal mortality and NSMM. The value of a statistical life,65 currently around $10 million, will be used to monetize prevented maternal deaths. For NSMM, we will calculate intervention costs per point of NSMM score reduction. Costs (and savings) in future years will be discounted to present value in the year of treatment initiation using a 3% discount rate.66
2.11. Analyses.
Tests will be two-sided (p<=0.05) and we will report measures of clinical significance (i.e., effect sizes).
2.11.1. Difference-in-differences (DiD) and propensity score methods.
The intervention evaluation will use DiD with period-specific propensity score kernel weighting.67–69 The standard DiD method ameliorates potential selection bias by subtracting the difference in outcomes between intervention and comparison groups at the pre-intervention, baseline, period (i.e., the systematic difference) from the difference in outcomes between intervention and comparison groups after the implementation (post-intervention). To minimize the potential bias induced by groups systematically changing over time, as the intervention counties are anticipated to increase participation in EPC of high-risk women through telehealth, we will use a propensity score weighted DiD method that balances the groups pre- and post-intervention. The method will ensure that the pre-comparison, post-comparison, pre-intervention, and post-intervention groups will have similar demographic, geographic, and medical backgrounds. Using period-specific propensity score kernel weighting in the DiD analysis is better than standard matching only at baseline because: (1) the latter may create regression to the mean problem70, and (2) it does not rely on a limited number of control individuals for each treated woman, allowing a larger sample to be leveraged. We will account for within-patient correlation (i.e., women with repeat pregnancies) using standard statistical techniques.
2.11.2. Missing data.
Data on pregnancy-related mortality is anticipated to be complete. Outcomes defined based on claims up to one year postpartum will be defined per the number of months with Medicaid coverage assessed. All women in Michigan retain Medicaid insurance at least eight weeks after birth, and most (~70%) retain Medicaid coverage through the first postpartum year.
2.11.3. Estimation procedures and effect testing.
The DiD equation is set up as follows, with Y being the outcomes of interest, the intervention indicator taking the value 1 if the observation is in the intervention counties, and 0 if in comparison counties and the post indicator taking the value 1 if the observation is in 2022–2025, and 0 if in 2016–2019. The key parameter to our analysis is , the DiD effect of the intervention. Propensity score period-specific kernel weights will be used in the DiD regression estimation so that the 4 groups (intervention pre, intervention post, comparison pre, comparison post) will be similar71 on the set of covariates described above. For each outcome of interest, we will first estimate the intervention effects among AAs. Then, we will estimate the effects on the AA-NHW disparities by adding an interaction term between the AA-NHW race indicator and .
2.11.3.1. Aim 1. Intervention main effects.
We will use the strategy described above to test intervention main effects on: (1) AA SMM (primary); (2) AA SMM and pregnancy-related mortality (1 if either; 0 otherwise); (3) AA-NHW disparities in SMM; (4) AA-NHW disparities in (SMM + mortality); (5) AA overall NSMM; (6) AA direct NSMM; (7) AA indirect NSMM; (8) AA co-incidental NSMM; (9) AA-NHW disparities in overall NSMM; (10) AA-NHW disparities in direct NSMM; (11) AA-NHW disparities in indirect NSMM; and (12) AA-NHW disparities in co-incidental NSMM.
2.11.3.2. Aim 2: Mechanisms of intervention effects.
We will separately test the hypotheses that, relative to AA women from comparison counties, AA women from intervention counties will have better service utilization (three separate measures: EPC participation = yes, more outpatient visits, fewer ED visits) and less NSMM, our proposed mechanisms. We will then test the hypothesis that service utilization and NSMM (1) predict AA SMM, and (2) mediate the effects of the intervention on AA SMM in a structural equation model framework. Statistical significance of the indirect effect will be assessed using bias-corrected bootstrapped standard errors. 72
2.11.3.3. Aim 3: Cost-effectiveness analyses.
We will conduct cost analysis and cost effectiveness analyses of the multilevel intervention relative to the status quo in non-intervention counties. We will conduct the cost effectiveness analyses both from the payer perspective, focusing on costs directly incurred to implement the program, and from the societal perspective, considering all costs regardless of source.
2.11.3.4. Moderators.
We will explore Hispanic ethnicity, age, first pregnancy, education, marital status, and prenatal chronic disease burden (additive score of disease indicators) as moderators of the effects of the intervention on AA SMM.
Conclusion
AA women face addressable disparities in maternal morbidity and mortality. This trial will help build the evidence base to address these disparities. The study will provide cost-effectiveness information needed to drive policy and practice decisions (e.g., sustained Medicaid reimbursement of telehealth EPC, national scale up of AIM-CCI bundles). It will also provide information about mechanisms of intervention effects needed to advance science.
One of the unique factors of this study is its focus during the design, execution, and dissemination of results on inclusion, representation, and community participation. The interventions being tested were designed by or in equal partnership with their end-users (including AA women, EPC staff and leaders, and providers from intervention counties). Interventions are offered in a way that continues this engagement; community partners lead all three interventions with support from the study team. In fact, academic partners wrote the study grant application because they knew of community efforts that were important to their community partners that could use additional effort and financial and technical support. Community partners brought interventions, commitment to finding ways to address pressing practical and clinical issues, and knowledge of community, system, and policy priorities. Academic partners brought a knowledge of the research literature, conceptual models, and experience with research design and grant-writing. During proposal preparation, community partners met twice per week with academic partners, discussed their interests in the project, and agreed to leverage their social capital to help meet study aims. This partnered approach ensures relevance, increases community ownership, and enhances sustainability.77 Most population-level studies involving multi-level interventions do not include this level of community engagement or attention to the representativeness of the study team; our study provides an example others can follow.
This project adheres to rigorous standards for causal inference (the quasi-experimental design, use of DiD with propensity score methods, reporting assumptions for creating propensity scores and the resulting balance and overlap).73 Rigor and reproducibility are also ensured by clear research questions, a priori data analysis plans, use of a large linked Medicaid and vital records dataset, reliable and valid measures, transparent statistical and power analyses, sufficient power, valid statistical methods to address missing data, detailed intervention manuals, and fidelity evaluation. Potential limitations include unobserved factors that can induce bias after propensity score matching using observable characteristics, potential incomplete or inaccurate observations in administrative data, and inability to determine effects of each intervention level separately.
It is unusual to try to assess population-level effects of a multilevel intervention mounted by an investigative team. This study provides an example of how to do so.
Table 1.
Glossary of Terms and Abbreviations
AA: African-American |
AIM-CCI: Alliance for Innovation on Maternal health Community Care Initiative (AIM-CCI) is an effort by the National Healthy Start Association, supported by the U.S. Health Resources and Services Administration, to develop and implement non-hospital, community care maternal safety bundles. CDC: Centers for Disease Control and Prevention |
Community health workers: trained, often race-concordant, peers who are employed to provide health education, support, and advocacy. As trusted members of the community, they facilitate access to services and improve the quality and cultural competence of service delivery. COVID-19: Coronavirus Disease 2019 |
Difference-in-differences (DiD): quasi-experimental approach to estimate intervention effects by comparing changes over time in intervention vs. control group. |
ED: emergency department |
Enhanced prenatal and postnatal care (EPC): targets improved birth outcomes through home visiting, care coordination, education, and support. In Michigan, the two primary EPC providers are: Maternal Infant Health Program (MIHP): home visitation program for Medicaid eligible women and infants in Michigan Healthy Start is a federal program dedicated to reducing disparities in maternal and infant health in high risk communities |
ICD-10: International Statistical Classification of Diseases74 |
MDHHS Health Services Data Warehouse: administrative linked dataset maintained by MDHHS, including vital records, Medicaid claims, and other data |
Michigan Department of Health and Human Services (MDHHS): State of Michigan Department that oversees health policy, population health, and provides public assistance and child/family welfare |
MIRACLE: Maternal Health Multilevel Intervention for Racial Equity |
NHW: Non-Hispanic white |
Non-severe maternal morbidity (NSMM): any health condition attributed to or complicating pregnancy or childbirth that have a negative impact on the woman’s well-being and functioning (e.g., gestational hypertension, obstetric complications, infections, endocrine, nutritional, and metabolic diseases, mental disorders).61–63 |
Propensity score methods: statistical method to estimate intervention effects in the absence of randomization RE-AIM: reach, effectiveness, adoption, implementation, maintenance |
Severe maternal morbidity (SMM): unexpected outcomes of labor and delivery that result in significant short- or long-term consequences to a woman’s health (e.g., eclampsia). |
Acknowledgments.
We would like to acknowledge the partnership and diligent work of many community organizations and partners in this project, who work tirelessly on behalf of women’s health in our counties. These partners include Genesee and Kent County MIHP and Healthy Start Programs, Spectrum Health, Genesee County Health Department, Hurley Medical Center, Ascension Health, the Healthy Kent Infant Health Action Team, the maternal health actionable anti-racism workshop team (Rev. Sarah Bailey, Ms. Bettina Campbell, Dr. E. Hill De Loney, Ms. Marjorie Evans, Ms. Ella Greene-Moton, Bishop Bernadel Jefferson, Ms. Sharon Saddler, Ms. Arlene Sparks, and Dr. Kent Key), Community Based Organization Partners, Hannah Nelsen, Genesee County Medical Society, provider and EPC provider champions, and other AA women community leaders in both counties (including Ms. Kenyetta Dotson, Dr. Maji Debena, Ms. Denise Evans, Ms. Sarah Bryant, Ms. Celeste Sanchez-Lloyd).
Funding, oversight, and trial registration.
This non-randomized pragmatic trial was funded by the National Institute on Minority Health and Health Disparities (NIMHD; R01 MD016003; Principal Investigators Johnson and Meghea). NIMHD did not participate in study design; in data collection, analysis, or interpretation; in writing the report; or in the decision to submit the article for publication. This study was deemed exempt by the Michigan State University Biomedical Institutional Review Board (FWA #00004556). There is no identifiable data and no trial monitoring. The trial is registered at clinicaltrials.gov (NCT ID not yet assigned).
Footnotes
Competing interests. The authors have no competing interests.
Dissemination policy. We can share fidelity data generated by the project, but we cannot share routinely collected MDHHS Health Services Data Warehouse data accessed by this project because it will not be generated by the project. Access to MDHHS data requires a data use agreement and a specific request to MDHHS from each research team. Study results will be shared widely with community, practice, and policy partners using a variety of approaches, as well as through standard academic channels.
Contributor Information
Jennifer E. Johnson, Division of Public Health, Michigan State University College of Human Medicine, 200 East 1st St Room 366, Flint, MI 48502.
LeeAnne Roman, Department of Obstetrics, Gynecology, and Reproductive Biology, Michigan State University College of Human Medicine, 965 Wilson Rd, Room, Room A629B East Lansing , MI 48823.
Kent D. Key, Division of Public Health, Michigan State University College of Human Medicine, 200 East 1st St Room 367, Flint, MI 48502.
Margaret Vander Meulen, Strong Beginnings – Healthy Start, 751 Lafayette NE, Grand Rapids, MI 49503..
Jennifer E. Raffo, Department of Obstetrics, Gynecology, and Reproductive Biology, Michigan State University College of Human Medicine, MSU Secchia Center, 15 Michigan St. NE, Grand Rapids, MI 49503..
Zhehui Luo, Department of Epidemiology and Biostatistics, Michigan State University College of Human Medicine, B627 West Fee Hall, 909 Wilson Road, East Lansing, MI 48823.
Claire E. Margerison, Department of Epidemiology and Biostatistics, Michigan State University College of Human Medicine, 909 Wilson Rd. Rm 601B, East Lansing, MI 48823.
Adesuwa Olomu, Department of Medicine, Michigan State University College of Human Medicine, B323 Clinical Center, East Lansing, MI 48824.
Vicki Johnson-Lawrence, Department of Family Medicine, Michigan State University College of Human Medicine, B106 Clinical Center, 788 Service Road, East Lansing, MI 48824.
Jonne McCoy White, Division of Public Health, Michigan State University College of Human Medicine, 200 East 1st St Room 371, Flint, MI 48502.
Cristian Meghea, Department of Obstetrics, Gynecology, and Reproductive Biology, Michigan State University College of Human Medicine, 965 Wilson Rd, Room A627, East Lansing , MI 48823, USA.
References
- 1.Kassebaum NJ, Barber RM, Bhutta ZA, et al. Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet 2016;388(10053):1775–1812. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Centers for Disease Control and Prevention. Reproductive Health, Pregnancy Mortality Surveillance System https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-surveillance-system.htm. Accessed May, 2020.
- 3.Petersen EE, Davis NL, Goodman D, et al. Vital signs: pregnancy-related deaths, United States, 2011–2015, and strategies for prevention, 13 states, 2013–2017. Morbidity and Mortality Weekly Report 2019;68(18):423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.American College of Obstetricians Gynecologists. Severe maternal morbidity: screening and review. Am J Obstet Gynecol 2016;215:B17–B22. [DOI] [PubMed] [Google Scholar]
- 5.Howell EA, Janevic T, Hebert PL, Egorova NN, Balbierz A, Zeitlin J. Differences in morbidity and mortality rates in black, white, and Hispanic very preterm infants among New York City hospitals. JAMA pediatrics 2018;172(3):269–277. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Vesco KK, Ferrante S, Chen Y, Rhodes T, Black CM, Allen-Ramey F. Costs of Severe Maternal Morbidity During Pregnancy in US Commercially Insured and Medicaid Populations: An Observational Study. Maternal and Child Health Journal 2020;24(1):30–38. [DOI] [PubMed] [Google Scholar]
- 7.Creanga AA, Bateman BT, Kuklina EV, Callaghan WM. Racial and ethnic disparities in severe maternal morbidity: a multistate analysis, 2008–2010. American Journal of Obstetrics and Gynecology 2014;210(5):435. e431–435. e438. [DOI] [PubMed] [Google Scholar]
- 8.Leonard SA, Main EK, Scott KA, Profit J, Carmichael SL. Racial and ethnic disparities in severe maternal morbidity prevalence and trends. Annals of epidemiology 2019;33:30–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.National_Institutes_of_Health. Addressing racial disparities in matneral mortality and morbidity (R01 clinical trial optional) 2020; https://grants.nih.gov/grants/guide/rfa-files/RFA-MD-20-008.html. Accessed April 30, 2020.
- 10.Howell E Reducing disparities in severe maternal morbidity and mortality. Clin Obstet Gynecol 2018;61(2):387–399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Center_for_Reproductive_Rights. Black Mamas Matter: Advancing the human right to safe and respectful maternal health care Center for Reproductive Rights;2018. [Google Scholar]
- 12.Black_Mamas_Matter_Alliance. Black Mamas Matter Alliance 2020; https://blackmamasmatter.org/. Accessed April 30, 2020.
- 13.Vilda D, Wallace M, Dyer L, Harville E, Theall K. Income inequality and racial disparities in pregnancy-related mortality in the US. SSM-population health 2019;9:100477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kruger D, French-Turner T, Brownlee S. Genesee County REACH windshield tours: Enhancing health professionals understeanding of community conditions that influence infant mortality. J Prim Prev 2013;34(3):163–172. [DOI] [PubMed] [Google Scholar]
- 15.Mayne SL, Pool LR, Grobman WA, Kershaw KN. Associations of neighbourhood crime with adverse pregnancy outcomes among women in Chicago: analysis of electronic health records from 2009 to 2013. J Epidemiol Community Health 2018;72(3):230–236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Meghea CI, Raffo JE, Zhu Q, Roman L. Medicaid home visitation and maternal and infant healthcare utilization. American Journal of Preventive Medicine 2013;45(4):441–447. [DOI] [PubMed] [Google Scholar]
- 17.Roman LA, Raffo JE, Zhu Q, Meghea CI. A statewide medicaid enhanced prenatal care program: impact on birth outcomes. JAMA Pediatrics 2014;168(3):220–227. [DOI] [PubMed] [Google Scholar]
- 18.Brown KK, Johnson C, Spainhower M, Phillips NF, Maryman JV. Is Timing of Enrollment Associated with Birth Outcomes? Findings from a Healthy Start Program in Kansas. Maternal and Child Health Journal 2017;21(1):25–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Salihu HM, Mbah AK, Jeffers D, Alio AP, Berry L. Healthy Start Program and Feto-Infant Morbidity Outcomes: Evaluation of Program Effectiveness. Maternal and Child Health Journal 2008;13(1):56. [DOI] [PubMed] [Google Scholar]
- 20.Applegate M, Gee RE, Martin JNJ. Improving Maternal and Infant Health Outcomes in Medicaid and the Children’s Health Insurance Program. Obstetrics & Gynecology 2014;124(1):143–149. [DOI] [PubMed] [Google Scholar]
- 21.Krans EE, Davis MM. Preventing low birthweight: 25 years, prenatal risk, and the failure to reinvent prenatal care. American Journal of Obstetrics and Gynecology 2012;206(5):398–403. [DOI] [PubMed] [Google Scholar]
- 22.Larson A, Berger LM, Mallinson DC, Grodsky E, Ehrenthal DB. Variable Uptake of Medicaid-Covered Prenatal Care Coordination: The Relevance of Treatment Level and Service Context. Journal of community health 2018:1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Howell EA, Zeitlin J. Improving hospital quality to reduce disparities in severe maternal morbidity and mortality. Seminars in perinatology 2017;41(5):266–272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Attanasio L, Kozhimannil KB. Health care engagement and follow-up after perceived discrimination in maternity care. Medical care 2017;55(9):830–833. [DOI] [PubMed] [Google Scholar]
- 25.Rankin KM, David RJ, Collins JW Jr. African American women’s exposure to interpersonal racial discrimination in public settings and preterm birth: the effect of coping behaviors. Ethnicity and Disease 2011;21(3):370. [PubMed] [Google Scholar]
- 26.Coley SL, Zapata JY, Schwei RJ, et al. More than a “number”: perspectives of prenatal care quality from mothers of color and providers. Women’s Health Issues 2018;28(2):158–164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Roman LA, Raffo JE, Dertz K, et al. Understanding perspectives of African American Medicaid-insured women on the process of perinatal care: an opportunity for systems improvement. Maternal and Child Health Journal 2017;21(1):81–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Mehta PK, Carter T, Vinoya C, Kangovi S, Srinivas SK. Understanding high utilization of unscheduled care in pregnant women of low socioeconomic status. Women’s Health Issues 2017;27(4):441–448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Moaddab A, Dildy GA, Brown HL, et al. Health care disparity and pregnancy-related mortality in the United States, 2005–2014. Obstetrics & Gynecology 2018;131(4):707–712. [DOI] [PubMed] [Google Scholar]
- 30.Kruger C, Carty DC, French-Turner TM, & Brownlee S. Undoing Racism Through Genesee County’s REACH Infant Mortality Reduction Initiative. Prog Community Health Partnerships 2015;9(1):57–63. [DOI] [PubMed] [Google Scholar]
- 31.REACH_Team_Evaluators. ACEDC Middle Passage and Racism 101, Flint MI, March 28-30, 2012. [Google Scholar]
- 32.U.S. Department of Health and Human Services. Addressing Racial Disparities in Maternal Mortality and Morbidity 2020; https://grants.nih.gov/grants/guide/rfa-files/RFA-MD-20-008.html. Accessed May 2020.
- 33.Council_on_Patient_Safety_in_Women’s_Health_Care. Patient Safety Bundles 2020; https://safehealthcareforeverywoman.org/patient-safety-bundles/#link_tab-maternal. Accessed May 2, 2020.
- 34.Carty D, Kruger DJ, Turner TM, Campbell B, De Loney EH, Lewis EY. Racism, health status, and birth outcomes: results of a participatory community-based intervention and health survey. J Urban Health 2011;88(1):84–97. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Selig S, Tropiano E, Greene-Moton E. Teaching cultural competence to reduce health disparities. Health Promotion Practice 2006;7(3 Suppl):247S–255S. [DOI] [PubMed] [Google Scholar]
- 36.Pestronk R, Franks ML, REACH_Team, Healthy_Start_Team, PRIDE_Team. A partnership to reduce African American infant mortality in Genesee County, Michigan. Public Health Reports 2003;118(4):324–335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Shultz C, Skorcz S. African American Infant Mortality and the Genesee County, MI REACH 2010 Initiative: An Evaluation of the Undoing Racism Workshop. Social Work in Public Health 2012;27(2):567–603. [DOI] [PubMed] [Google Scholar]
- 38.Meghea CI, You Z, Raffo J, Leach RE, Roman LA. Statewide Medicaid Enhanced Prenatal Care Programs and Infant Mortality. Pediatrics 2015. [DOI] [PubMed] [Google Scholar]
- 39.Roman LA RJ, Strutz KL, Luo Z et al. The impact of a population-based system of care intervention on enhanced prenatal care and service utilization among Medicaid-insured pregnant women. Am J Prev Med 2022;62(2):e117–e127. [DOI] [PubMed] [Google Scholar]
- 40.Kilbourne AM, Neumann MS, Pincus HA, Bauer MS, Stall R. Implementing evidence-based interventions in health care: application of the replicating effective programs framework. Implementation Science 2007;2:42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Glasgow RER, WJ. RE-AIM website: Improving public health relevance and population health impact 2016; http://re-aim.org/. Accessed December 20, 2016.
- 42.Carty DC. Qualitative evaluation report: Community-based participatory approaches to reducing racial disparities in infant mortality University of Michigan;2013. [Google Scholar]
- 43.Johnson JE, Wiltsey-Stirman S, Sikorskii A, et al. Protocol for the ROSE sustainment (ROSES) study, a sequential multiple assignment randomized trial to determine the minimum necessary intervention to maintain a postpartum depression prevention program in prenatal clinics serving low-income women. Implementation Science 2018;13(1):115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Johnson JE, Stout RL, Miller TR et al. Randomized cost-effectiveness trial of group interpersonal psychotherapy (IPT) for prisoners with major depression. Journal of Consulting and Clinical Psychology 2019;87(4):392–406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Johnson JE MT, Stout RL, Zlotnic C, Cerbo LA, Andrade JT, Wiltsey-Stirman S. Study protocol: Hybrid Type I cost-effectiveness and implementation study of interpersonal psychotherapy (IPT) for men and women prisoners with major depression. Contemporary Clinical Trials 2016;47:266–274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Johnson JE, Hailemariam M, Zlotnick C et al. Mixed methods analysis of implementation of Interpersonal Psychotherapy (IPT) for major depressive disorder in prisons in a Hybrid Type I randomized trial. Administration and Policy in Mental Health and Mental Health Services Research 2019; 10.1007/s10488-019-00996-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Proctor EK, Powell BJ, McMillen JC. Implementation strategies: recommendations for specifying and reporting. Implementation Science 2013;8:139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Powell BJ, Waltz TJ, Chinman MJ, et al. A refined compilation of implementation strategies: results from the Expert Recommendations for Implementing Change (ERIC) project. Implementation Science 2015;10:21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: Final Data for 2017. National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System 2018;67(8):1–50. [PubMed] [Google Scholar]
- 50.MACPAC. Medicaid’s Role in Financing Maternity Care January 2020. [Google Scholar]
- 51.Lyndon A, Baer RJ, Gay CL, El Ayadi AM, Lee HC, Jelliffe-Pawlowski L. A population-based study to identify the prevalence and correlates of the dual burden of severe maternal morbidity and preterm birth in California. The Journal of Maternal-Fetal & Neonatal Medicine 2021. Apr;34(8):1198–1206 [DOI] [PubMed] [Google Scholar]
- 52.Wang E, Glazer KB, Howell EA, Janevic TM. Social Determinants of Pregnancy-Related Mortality and Morbidity in the United States: A Systematic Review. Obstetrics & Gynecology 2020;135(4):896–915. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Garcia E, McKane P. Medicaid Enrollment Analysis on Maternal Mortality Cases Lansing, MI: Michigan Department of Community Health, Lifecourse Epidemiology and Genomics Division;January 2015. [Google Scholar]
- 54.Oquendo M, Stanley B, Ellis SP. Protection of human subjects in intervention research for suicidal behavior. AM J Psychiatry 2004;161(9):1558–1563. [DOI] [PubMed] [Google Scholar]
- 55.Johnson J, Jones R, Miller T et al. Study protocol: A randomized controlled trial of suicide risk reduction in the year following jail release (the SPIRIT Trial). Contemporary Clinical Trials 2020;94:106003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.DiversityDataKids. Child Opportunity Index (COI) 2022; https://www.diversitydatakids.org/child-opportunity-index. Accessed 5-16-22, 2022.
- 57.Kind A, Buckingham JR. Making neighborhood disadvantage metrics accessible - the neighborhood atlas. NEJM 2018;378(26):2456–2458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.University_of_Wisconsin_Department_of_Medicine. Neighborhood Atlas 2021; https://www.neighborhoodatlas.medicine.wisc.edu/. Accessed 5-28-21, 2021.
- 59.Centers for Disease Control and Prevention. Reproductive Health. How does CDC Identify Severe Maternal Morbidity? https://www.cdc.gov/reproductivehealth/maternalinfanthealth/smm/severe-morbidity-ICD.htm. Accessed May, 2020.
- 60.Firoz T, McCaw-Binns A, Filippi V, et al. A framework for healthcare interventions to address maternal morbidity. International Journal of Gynecology & Obstetrics 2018;141:61–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Firoz T, Chou D, von Dadelszen P, et al. Measuring maternal health: focus on maternal morbidity. Bulletin of the World Health Organization 2013;91:794–796. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Chou D, Tunçalp Ö, Firoz T et al. Constructing maternal morbidity–towards a standard tool to measure and monitor maternal health beyond mortality. BMC pregnancy and childbirth 2016;16(1):45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Say L, Chou D, Group WMMW. Maternal morbidity: Time for reflection, recognition, and action. International Journal of Gynaecology and Obstetrics 2018;141(Suppl Suppl 1):1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.World Health Organization. The WHO application of ICD-10 to deaths during pregnancy, childbirth and puerperium: ICD MM [Google Scholar]
- 65.Kniesner TJ, Viscusi WK. The Value of a Statistical Life. Forthcoming, Oxford Research Encyclopedia of Economics and Finance 2019:19–15. [Google Scholar]
- 66.Gold M, Siegel JE, Russell LB, Weinstein MC, ed Cost-Effectiveness in Health and Medicine New York: Oxford University Press; 1996. [Google Scholar]
- 67.Ryan AM, Burgess JF Jr, Dimick JB. Why we should not be indifferent to specification choices for difference-in-differences. Health services research 2015;50(4):1211–1235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Lindner S, McConnell KJ. Difference-in-differences and matching on outcomes: a tale of two unobservables. Health Services and Outcomes Research Methodology 2019;19(2–3):127–144. [Google Scholar]
- 69.Villa JM. Simplifying the estimation of difference-in-differences treatment effects. The Stata Journal 2016;16(1):52–71. [Google Scholar]
- 70.Daw JR, Hatfield LA. Matching and regression to the mean in difference-in-differences analysis. Health services research 2018;53(6):4138–4156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Stuart EA, Huskamp HA, Duckworth K, et al. Using propensity scores in difference-in-differences models to estimate the effects of a policy change. Health Services and Outcomes Research Methodology 2014;14(4):166–182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods 2002;7(1):83–104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Patient-Centered Outcomes Research Institute. PCORI Methodology Standards February 2019. [Google Scholar]
- 74.World_Health_Organization. International Statistical Classification of Diseases and Related Health Problems 2022; https://www.who.int/standards/classifications/classification-of-diseases. Accessed May 6, 2022.
- 75.Michigan Department of Health and Human Services. Michigan Infant Mortality 2020; https://www.michigan.gov/mdhhs/0,5885,7-339-73970_2944_4669_4694---,00.html. Accessed May, 2020.
- 76.Centers for Disease Control and Prevention. HEAR HER Campaign https://www.cdc.gov/hearher/index.html. Accessed August 9, 2022.
- 77.Schediac-Rizkallah MC, Bone LR. Planning for the sustainability of community-based health programs: Conceptual frameworks and future directions of research, practice and policy. Health education research 1998;13(1):87–108. [DOI] [PubMed] [Google Scholar]